Who is sponsoring NCT03824665?

NCT03824665 is sponsored by Cairo University.

What drugs are being tested in NCT03824665?

Interventions in NCT03824665: Nalbuphine Group, Fentanyl Group, Control Group.

What condition does NCT03824665 study?

NCT03824665 studies Nalbuphine,Fentanyl and Local Anesthetic Mixture.

Is NCT03824665 still recruiting?

NCT03824665 is currently completed. Last updated 21 May 2019.

Last reviewed 2019-05-21 · How we verify

NCT03824665

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nalbuphine, Fentanyl and no Additive to Local Anaesthetic Mixture

Completed Phase 4 Last updated 21 May 2019

What this trial tests

Phase 4 trial testing Nalbuphine Group in Nalbuphine,Fentanyl and Local Anesthetic Mixture in 120 participants. Completed in 18 May 2019.

Timeline

5 February 2019

Primary endpoint
10 May 2019

18 May 2019

Quick facts

Lead sponsor	Cairo University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	120
Start date	5 February 2019
Primary completion	10 May 2019
Estimated completion	18 May 2019
Sites	1 location across Egypt

Drugs / interventions tested

Nalbuphine Group
Fentanyl Group
Control Group — full drug profile →

Conditions studied

Nalbuphine,Fentanyl and Local Anesthetic Mixture — all drugs for Nalbuphine,Fentanyl and Local Anesthetic Mixture →

Sponsor

Cairo University

Who can join

Adults 40 to 70, any sex, with Nalbuphine,Fentanyl and Local Anesthetic Mixture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal,epidural, caudal anesthesia and peripheral nerve blocks showing an increase in the efficacy and the duration of postoperative analgesia. The aim of this study is evaluation of the effect of 4 mg Nalbuphine when used as an adjuvant to a local anesthetic mixture in peribulbar block undergoing posterior chamber surgery in adult patients and comparing it with adding Fentanyl 20 μg to LAM and LAM alone

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03824665 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03824665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing